Clinical Evaluation of Bath Additive containing Oily Moisturizer(NOV Medicated Bathessence) on Dry Skin of Atopic Dermatitis and Astheatotic Dermatitis.
スポンサーリンク
概要
- 論文の詳細を見る
The clinical efficacy and safety of bath additive containing oily moisturizer (NOV Medicated Bathessence<SUP>®</SUP>) was evaluated in 27 cases (atopic dermatitis and astheatotic dermatitis and etc.)<BR>The improvement ratio of dry skin (taking into account moderate to marked improvements) was 63.0% and utility ratio (taking into account moderately to very useful) was 66.7%. The side effect was not observed and safety ratio was 100%.<BR>From the results, it was considered that NOV Medicated Bathessence<SUP>®</SUP> was absolutely safe and helpful for the treatment of dry and sensitive skin like atopic dermatitis and astheatotic dermatitis.
- 日本皮膚科学会大阪地方会の論文
日本皮膚科学会大阪地方会 | 論文
- ツベルクリン皮内反応部に出現する浸潤細胞の電顕的観察
- セフメタゾ-ル・ナトリウムによりSystemic eczematous contact-type dermatitis medicamentosaと急性腎不全を生じた1例 (単純化学物質による皮膚障害)
- 歯科金属アレルギ-による全身の扁平苔癬の1例 (接触皮膚炎とパッチテスト-4-)
- Oakmoss Allergyを示すPigmented Cosmetic Dermatitisの1例 (単純化学物質による皮膚障害)
- 漢方薬中のCinnamic系化合物による薬疹の1例 (単純化学物質による皮膚障害) -- (職業性および薬剤性皮膚炎と薬疹)